Trial Details
RECRUITINGBasic Information
| Clinical ID | c159 |
|---|---|
| Identifier | NCT07071519 |
| Trial Title | A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Risankizumab|DRUG: Risankizumab |
Participant Information
| Sponsor | AbbVie |
|---|---|
| City | Phoenix |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-07-28 |
|---|---|
| Primary Completion Date | 2034-07 |
| Completion Date | 2034-07 |